vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
COLLEGIUM PHARMACEUTICAL, INC的季度营收约是RESOURCES CONNECTION, INC.的1.7倍（$205.4M vs $117.7M），COLLEGIUM PHARMACEUTICAL, INC净利率更高（8.3% vs -10.8%，领先19.0%），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs -19.2%），COLLEGIUM PHARMACEUTICAL, INC自由现金流更多（$122.4M vs $15.6M），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs -11.8%）
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
COLL vs RGP — 直观对比
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $117.7M |
| 净利润 | $17.0M | $-12.7M |
| 毛利率 | 62.5% | 37.1% |
| 营业利润率 | 29.6% | -10.3% |
| 净利率 | 8.3% | -10.8% |
| 营收同比 | 12.9% | -19.2% |
| 净利润同比 | 35.3% | 81.6% |
| 每股收益（稀释后） | $0.48 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $205.4M | $117.7M | ||
| Q3 25 | $209.4M | $120.2M | ||
| Q2 25 | $188.0M | $139.3M | ||
| Q1 25 | $177.8M | $129.4M | ||
| Q4 24 | $181.9M | $145.6M | ||
| Q3 24 | $159.3M | $136.9M | ||
| Q2 24 | $145.3M | $148.2M | ||
| Q1 24 | $144.9M | $151.3M |
| Q4 25 | $17.0M | $-12.7M | ||
| Q3 25 | $31.5M | $-2.4M | ||
| Q2 25 | $12.0M | $-73.3M | ||
| Q1 25 | $2.4M | $-44.1M | ||
| Q4 24 | $12.5M | $-68.7M | ||
| Q3 24 | $9.3M | $-5.7M | ||
| Q2 24 | $19.6M | $10.5M | ||
| Q1 24 | $27.7M | $2.5M |
| Q4 25 | 62.5% | 37.1% | ||
| Q3 25 | 61.7% | 39.5% | ||
| Q2 25 | 57.7% | 40.2% | ||
| Q1 25 | 54.8% | 35.1% | ||
| Q4 24 | 54.0% | 38.5% | ||
| Q3 24 | 60.8% | 36.5% | ||
| Q2 24 | 62.5% | 40.2% | ||
| Q1 24 | 63.1% | 37.0% |
| Q4 25 | 29.6% | -10.3% | ||
| Q3 25 | 29.7% | -1.7% | ||
| Q2 25 | 18.7% | -47.0% | ||
| Q1 25 | 12.2% | -38.4% | ||
| Q4 24 | 20.9% | -52.7% | ||
| Q3 24 | 21.9% | -3.5% | ||
| Q2 24 | 32.7% | 7.6% | ||
| Q1 24 | 34.1% | 2.8% |
| Q4 25 | 8.3% | -10.8% | ||
| Q3 25 | 15.0% | -2.0% | ||
| Q2 25 | 6.4% | -52.6% | ||
| Q1 25 | 1.4% | -34.0% | ||
| Q4 24 | 6.9% | -47.2% | ||
| Q3 24 | 5.9% | -4.2% | ||
| Q2 24 | 13.5% | 7.1% | ||
| Q1 24 | 19.1% | 1.7% |
| Q4 25 | $0.48 | $-0.38 | ||
| Q3 25 | $0.84 | $-0.07 | ||
| Q2 25 | $0.34 | $-2.21 | ||
| Q1 25 | $0.07 | $-1.34 | ||
| Q4 24 | $0.36 | $-2.08 | ||
| Q3 24 | $0.27 | $-0.17 | ||
| Q2 24 | $0.52 | $0.31 | ||
| Q1 24 | $0.71 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $386.7M | $89.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $301.7M | $194.6M |
| 总资产 | $1.7B | $289.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $386.7M | $89.8M | ||
| Q3 25 | $285.9M | $77.5M | ||
| Q2 25 | $222.2M | $86.1M | ||
| Q1 25 | $197.8M | $72.5M | ||
| Q4 24 | $162.8M | $78.2M | ||
| Q3 24 | $120.0M | $89.6M | ||
| Q2 24 | $271.6M | $108.9M | ||
| Q1 24 | $318.0M | $113.8M |
| Q4 25 | $301.7M | $194.6M | ||
| Q3 25 | $274.8M | $206.4M | ||
| Q2 25 | $232.2M | $207.1M | ||
| Q1 25 | $234.4M | $277.8M | ||
| Q4 24 | $228.8M | $325.7M | ||
| Q3 24 | $234.3M | $407.2M | ||
| Q2 24 | $216.6M | $418.8M | ||
| Q1 24 | $222.2M | $414.9M |
| Q4 25 | $1.7B | $289.3M | ||
| Q3 25 | $1.6B | $287.2M | ||
| Q2 25 | $1.6B | $304.7M | ||
| Q1 25 | $1.6B | $375.6M | ||
| Q4 24 | $1.7B | $424.9M | ||
| Q3 24 | $1.6B | $512.9M | ||
| Q2 24 | $1.1B | $510.9M | ||
| Q1 24 | $1.1B | $523.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.0M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $122.4M | $15.6M |
| 自由现金流率自由现金流/营收 | 59.6% | 13.2% |
| 资本支出强度资本支出/营收 | 0.3% | 0.3% |
| 现金转化率经营现金流/净利润 | 7.25× | — |
| 过去12个月自由现金流最近4个季度 | $327.6M | $24.3M |
8季度趋势，按日历期对齐
| Q4 25 | $123.0M | $15.9M | ||
| Q3 25 | $78.4M | $-7.8M | ||
| Q2 25 | $72.4M | $16.8M | ||
| Q1 25 | $55.4M | $659.0K | ||
| Q4 24 | $84.6M | $1.8M | ||
| Q3 24 | $-9.0M | $-309.0K | ||
| Q2 24 | $67.4M | $3.2M | ||
| Q1 24 | $61.9M | $20.5M |
| Q4 25 | $122.4M | $15.6M | ||
| Q3 25 | $78.3M | $-8.0M | ||
| Q2 25 | $72.4M | $16.5M | ||
| Q1 25 | $54.6M | $238.0K | ||
| Q4 24 | $84.1M | $61.0K | ||
| Q3 24 | $-9.2M | $-575.0K | ||
| Q2 24 | $67.1M | $3.0M | ||
| Q1 24 | $61.4M | $20.4M |
| Q4 25 | 59.6% | 13.2% | ||
| Q3 25 | 37.4% | -6.6% | ||
| Q2 25 | 38.5% | 11.8% | ||
| Q1 25 | 30.7% | 0.2% | ||
| Q4 24 | 46.2% | 0.0% | ||
| Q3 24 | -5.8% | -0.4% | ||
| Q2 24 | 46.2% | 2.1% | ||
| Q1 24 | 42.3% | 13.5% |
| Q4 25 | 0.3% | 0.3% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 0.3% | 1.2% | ||
| Q3 24 | 0.2% | 0.2% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 0.4% | 0.1% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | 0.30× | ||
| Q1 24 | 2.23× | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COLL
暂无分部数据
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
